Clinical Trial Update: OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

View source ↗

Summary

AstraZeneca-sponsored clinical trial NCT01694758 on optimal Type 2 diabetes management in CEEMEA was completed, including benchmarking against standard treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Status: COMPLETED